Article
Philadelphia chromosome-positive B-lymphoblastic lymphoma successfully treated with chemotherapy regimen containing imatinib: A rare case report and literature review.
Medicine - 11 Jun 2021
Li Xiaoning, Cao Weijie, Zhang Suping, Li Li, Li Yingmei, Jiang Zhongxing, Wan Dingming, Yu Jifeng
Abstract excerpt
RATIONALE: B-lymphoblastic lymphoma (B-LBL) with BCR/ABL mutation (Ph+ B-LBL) is a rare type of cancer in both childhood and adults. Its clinical manifestations are similar to those of other types lymphoma. However, the targeted therapy can substantially improve the outcome of Ph+ B-LBL. PATIENT CONCERNS: A 19-year-old male with blood type O, Rh+ was admitted into our hospital on August 14, 2018, due to a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
